Snapshot from Nov 22, 2026 at 07:00 UTC. For live data and tracking: View Live

United States & Johnson & Johnson

26 shared events · Importance 4 · Last updated Aug 12, 2026

Importance
4
Shared Events
26
Actions
0
Sentiment
0
Live sentiment trends, interaction importance charts, and action volume tracking available on the Ergen Dashboard
69
Business
United States: The US is part of North America, which held the largest market share in 2025, supported by strong regulatory frameworks and advanced manufacturing.
Johnson & Johnson: Johnson & Johnson is a key player in the antibody therapeutics market, benefiting from the projected market growth.
Jul 28, 2026 · 6 articles
63
Business
United States: Part of North American Cobalt Inc., the largest regional market with 38.5% share.
Johnson & Johnson: Key player; growth forecast positive for its medical devices segment.
Jul 21, 2026 · 8 articles
60
Accidents
United States: United States>>> has bolstered precautions, including screening air passengers and suspending visa services, and has provided $13 million in assistance for the response.
Johnson & Johnson: Johnson & Johnson Innovative Medicine is a key partner in the urgent high-level coordination meeting convened by United States — Centers for Disease Control and Prevention, potentially involved in assessing medical countermeasures for the Ebola outbreak.
May 15, 2026 · 446 articles
45
Tech
United States: The United States>>> is a key market for prostate cancer treatment, with a significant number of high-risk patients who could benefit from Apalutamide>>>.
Johnson & Johnson: The company developed and tested Apalutamide, a prostate cancer drug, which showed significant positive results in late-stage trials, potentially expanding its market and revenue.
May 31, 2026 · 6 articles
45
Regulatory
United States: The litigation is taking place in U.S. federal and state courts, affecting the company's operations in the U.S.
Johnson & Johnson: Johnson & Johnson is the defendant in the talc litigation; the judge's doubt on causation is favorable for the company, reducing the risk of large verdicts.
Jul 22, 2026 · 6 articles
45
Business
United States: The settlement resolves claims in U.S. federal and state courts, covering nearly all remaining talc lawsuits in the country.
Johnson & Johnson: Johnson & Johnson is the defendant proposing the $5.5 billion settlement to resolve most talc lawsuits, which could end a decade-long legal battle and reduce uncertainty.
Jul 27, 2026 · 82 articles
39
Tech
United States: The study focuses on U.S. populations, particularly the Southern Appalachian region, and may influence national screening guidelines and public health policy.
Johnson & Johnson: Johnson & Johnson's Rybrevant is another EGFR-targeted therapy referenced; the study could support broader use of these treatments.
Sep 17, 2026 · 6 articles
32
Domestic
United States: The US is a key partner, with multiple states proclaiming India Day and officials extending greetings, strengthening bilateral ties and economic cooperation.
Johnson & Johnson: US Congressman sent greetings, praising India's growth.
Aug 05, 2026 · 135 articles
28
International
United States: The United States successfully used a drone boat for a rescue mission near the Strait of Hormuz, highlighting its push to integrate autonomous technology into Middle East operations.
Johnson & Johnson: Johnson & Johnson, a supply chain consultant, warns that the war's impact on costs will filter through supply chains for the rest of the year, leading to bigger problems if oil shortages persist.
May 05, 2026 · 374 articles
26
Regulatory
United States: The U.S. is waging war on Iran alongside Israel, contributing to helium supply disruptions that prompted China's export ban.
Johnson & Johnson: Johnson & Johnson, senior partner at Tidalwave Solutions, stated that the ban indicates China knows there is not enough helium.
Apr 20, 2026 · 23 articles
26
Business
United States: US chip stocks and indices were affected, and the Fed's policy is a key factor for markets.
Johnson & Johnson: J&J rose after agreeing to pay $5.5 billion to resolve talc lawsuits.
Apr 20, 2026 · 190 articles
24
Domestic
United States: The United States also shuttered last week due to Donald Trump's demands, indicating a broader impact of his influence on the legislative process.
Johnson & Johnson: Johnson & Johnson, a Republican Representative, voiced frustration over the current state of Congress, stating that many colleagues have 'forgotten how to govern'.
Jun 29, 2026 · 17 articles
24
Regulatory
United States: Jurisdiction; political involvement via Trump administration; FDA and CDC mentioned.
Johnson & Johnson: Former parent of Kenvue; spun off in 2023, not directly involved but legacy exposure.
Jul 13, 2026 · 23 articles
22
Business
United States: The United States>>> is the target market for the biosimilar applications, with the United States — Food and Drug Administration>>> (FDA) being the regulatory authority for approval.
Johnson & Johnson: Johnson & Johnson>>> owns the trademarks for Simponi and Simponi Aria, the reference products for Alvogen>>>'s AVT05 biosimilar. The potential market entry of AVT05 could introduce competition to Johnson & Johnson>>>'s products.
Jun 04, 2026 · 10 articles
20
Domestic
United States: Media coverage and publication of memoir in US.
Johnson & Johnson: Demanded answers over media attacks, supporting the family's stance.
Aug 14, 2026 · 229 articles
17
Business
United States: The United States is the primary market for the therapies and the regulatory environment is influenced by the Trump administration's executive order.
Johnson & Johnson: Johnson & Johnson faces new competition in the treatment-resistant depression market as Lilly's acquisition of Atai Life Sciences positions BPL-003 as a potential rival to J&J's Spravato.
Jul 16, 2026 · 25 articles
14
Business
United States: The United States is the region where Roche and Nurix Therapeutics, Inc. will equally split profits and losses from the commercialization of bexobrutideg.
Johnson & Johnson: Johnson & Johnson is mentioned as a co-developer of an approved BTK inhibitor, Imbruvica, which is a competitor to bexobrutideg.
Jun 07, 2026 · 22 articles
0
Business
Dec 23, 2025 · 7 articles
0
Regulatory
Dec 19, 2025 · 7 articles
0
Business
Dec 13, 2025 · 20 articles
0
Business
Feb 04, 2026 · 7 articles
0
International
Jan 16, 2026 · 190 articles
0
Domestic
Mar 06, 2026 · 6 articles
0
International
Apr 16, 2026 · 760 articles
0
International
Apr 15, 2026 · 59 articles
0
Business
Johnson & Johnson: Johnson & Johnson is investing over $1 billion to expand its Vision operations in United States — Jacksonville, Florida, enhancing its manufacturing, packaging, and distribution capabilities for ACUVUE contact lenses. This investment is part of a larger $55 billion commitment to U.S. manufacturing, research, and development, aiming to strengthen its supply chain and meet growing demand.
Jun 15, 2026 · 12 articles
ERGEN INTELLIGENCE
Explore this relationship live

Track how United States and Johnson & Johnson interact across events, view sentiment trends, and discover connected entities.

Open Dashboard

About Ergen

Ergen is a news intelligence platform that converts raw news articles into structured data. It tracks events, entities, and the relationships between them, with sentiment and attention metrics derived from thousands of articles. Pages on this site are daily static snapshots from the platform's live database. For real-time tracking, search, and alerts, the full dashboard is at app.ergen.ai.